Mia Camille Hartman, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1448 Irish Hill Rd, Lowell, VT 05847 Phone: 802-272-4631 |
News Archive
Lisa Jo Rudy is a writer, a social media guru, and above all a parent of a child with an autism spectrum disorder. She knows first hand what it takes to get out, have fun and explore the world with autistic children. In her groundbreaking new book, "Get Out, Explore, and Have Fun: How Families of Children with Autism or Asperger Syndrome Can Get the Most Out of Community Activities," Lisa Jo Rudy explores options, offers tips and guides parents in their steps to get their children involved in life outside of home, school, and therapists' offices.
On April 22, 2004, the Chinese Ministry of Health reported a possible case of severe acute respiratory syndrome (SARS) in a 20-year-old woman who works as a nurse in a hospital in Beijing. If confirmed, this will be the first case of SARS since January 2004, when Chinese health authorities confirmed SARS coronavirus (SARS-CoV) infection in three persons in Guangdong Province.
Columbia Laboratories, Inc. announced today that it has closed the sale of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc.. Columbia's business now consists of its royalty and manufacturing revenues, potential milestone payments, its collaboration with Watson on the development of next-generation progesterone products, and its novel bioadhesive drug delivery technologies and other products.
Every day, thousands of volunteer medical relief groups offer care to patients and assistance to understaffed medical teams in remote, underdeveloped locations around the world. Often these groups of doctors and nurses come for a short time, offer care and return home.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
› Verified 8 days ago